Global Fund Board votes to begin immediate transition to new funding model

"In a bid to ensure the global fight against three of the world's most devastating diseases remains efficient, the Board of the ... Global Fund to Fight AIDS, Tuberculosis and Malaria voted [Thursday] to begin an immediate transition" to a new grant-funding approach, the U.N. News Centre reports (11/15). The new funding model "is designed to be simpler, more flexible, and have greater impact in conquering the diseases," according to Reuters. "The new system relies upon closer discussions with the recipient countries, along with other donor groups and experts, over the design of their disease-fighting programs"; "will focus on addressing the needs of the poorest countries with the highest number of infections"; and will allow flexible grant cycles "instead of falling in set time periods, so that they can be coordinated better with a country's budgetary cycle, [the Board] said," the news agency writes (Dawson, 11/15).

"A new funding model is designed to significantly improve the way the Global Fund invests in health programs, with a process that is more predictable and reliable, and also more flexible, so that it can achieve a higher success rate in all grants and more effectively save the lives of people affected by the three diseases," a Global Fund press release states. "The framework for the new funding model was adopted by the Board in September," but "the Board [Thursday] decided on additional aspects, including a transition to the new funding model starting in 2013," according to the press release (11/15).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development